Tranexamic Acid Oral Suspension (Anhydrous)
Tranexamic Acid is a compounded formulation containing Tranexamic Acid, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Tranexamic acid is an antifibrinolytic agent utilized in veterinary medicine for managing blood stability. It is a prescription medication available for use in dogs, requiring professional guidance from a licensed veterinarian. It is frequently considered in the context of emergency care for managing localized bleeding or prior to specific surgical procedures in breeds at risk for hemorrhage.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it manages the degradation of fibrin by inhibiting the activation of plasminogen, providing an approach for managing clot stability. Commonly observed effects include localized digestive changes such as vomiting or diarrhea. Because it influences the coagulation cascade, your veterinarian will monitor for observational signs of sensitivity. Owners should monitor for any unusual behavioral shifts and contact their veterinarian promptly with any concerns.
Yes. Tranexamic acid is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all requirements before Preparing any medication.
Veterinarians discuss tranexamic acid for specific breeds or conditions where blood clots might break down too quickly. This offers an approach to managing surgical safety and recovery.
Yes. Veterinarians may consider tranexamic acid to offer an approach to managing persistent localized bleeding. Your veterinarian will determine the most suitable administration route.
You should monitor for observational signs like improved comfort and a stop in active bleeding. If your pet appears unusually lethargic or continues to bleed, contact your veterinarian immediately.
Tranexamic acid is typically evaluated carefully in patients with a history of thromboembolic disease. Your veterinarian will determine if this approach is suitable for your individual pet.
